About Biot
Biot is a Healthcare company based in San Jose (United States) founded in 2017 by Yeongjun Chang and Sungkuk Park. It operates as a delivery systems for cell therapies are developed and targeted. Its chief executive is Yeongjun Chang. Its focus areas include Life Sciences, Regenerative Medicine, Biomaterials and Scaffolds. Its competitors include Humacyte, OrthAlign, Axial3D, Impel NeuroPharma and Cartiva and 3 more; 8 of its 8 listed competitors have raised funding.
Company details
Biot was founded in 2017 and is based in San Jose, United States. Operations focus on the biotechnology sector, where delivery systems for cell therapies are developed. The Stem Cell Navigator is engineered as a combination of micro-scaffold, electromagnetic actuator, and wearable device to position therapeutic stem cells at specific sites. Applications include treatments for degenerative arthritis and nervous system disorders.
- Headquarters San Jose, United States
- Founders Yeongjun Chang, Sungkuk Park
- SectorsHealthcare
- Email••••••••
- Website biotinc.com
People of Biot
2 people are tracked at Biot (2 in leadership).
| Name | Role | Group |
|---|---|---|
Yeongjun Chang | Co-Founder & CEO | Leadership |
Sungkuk Park | Co-Founder | Leadership |
Complete people profiles for Biot
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Biot
Biot has 8 listed competitors in our database, 8 of them funded. They include Humacyte, OrthAlign, Axial3D, Impel NeuroPharma and Cartiva, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| humacyte.com | 2004 | Morrisville, United States | $424.76M | 70 | Human tissue-based products are developed for vascular disease applications. | |
| orthalign.com | 2008 | Aliso Viejo, United States | $56M | 103 | Knee and hip alignment devices and technology | |
| axial3d.com | 2014 | Belfast, United Kingdom | $44.72M | 49 | Provider of cloud-based 3D-printed medical models and surgical guides | |
| impelnp.com | 2008 | Seattle, United States | $126.83M | 158 | Intranasal delivery technology for CNS diseases is developed. | |
| cartiva.net | 2011 | Alpharetta, United States | $22.81M | 36 | Synthetic cartilage implants are developed for osteoarthritis treatment. | |
| craniustherapeutics.com | 2021 | Baltimore, United States | $20.5M | – | Drug delivery systems for brain diseases and disorders are developed. | |
| shoulderinnovations.com | 2009 | Holland, United States | $139.29M | – | Total shoulder replacement solutions based on glenoid technology are provided. | |
| bioradmedisys.com | 2007 | Pune, India | $5.46M | 188 | Medical devices for orthopaedic, neurovascular, and endovascular procedures are manufactured. |
Detailed competitors of Biot
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Biot
The website of Biot (biotinc.com) receives about 5.3K visits a month.
- Monthly visits5.3K
▲ 18.7% vs previous month
Top companies in Neurology
10 companies that operate in the same segment as Biot (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | 541 | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biot
Biot was founded in 2017.
Biot is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Yeongjun Chang is the current CEO of Biot. They have also founded this company.
Biot was founded in 2017 and is based in San Jose, United States. Operations focus on the biotechnology sector, where delivery systems for cell therapies are developed. The Stem Cell Navigator is engineered as a combination of micro-scaffold, electromagnetic actuator, and wearable device to position therapeutic stem cells at specific sites. Applications include treatments for degenerative arthritis and nervous system disorders.